Abstract
The physiologic significance of the racemic 3-O-sulfate esters of epinephrine (EPI-3-O-S)
and norepinephrine (NE-3-O-S) as well as 4-O-sulfoconjugated dopamine (DA-4-O-S) was
evaluated. For this purpose these conjugated catecholamines (CA) were synthesized
and investigated with respect to their α2 - and β2 -adrenoceptor affinities and their biological activity in three different human cell
systems: in mononuclear leukocytes (MNL), platelets, and fat cells.
The unequivocal identification and the minimal degree of contamination of the synthesized
sulfoconjugates with free CA was proved by 1 H-NMR and by high-performance liquid chromatography with amperometric detection (HPLCA)
respectively. In isolated human MNL, β-adrenoceptor affinities of these conjugated
CA were determined in competition experiments with the lipophilic nonspecific radioligand
(-) 125 l-cyanopindolol (ICYP) and, in addition, with the hydrophilic ligand 3 H-CGP12177. With both ligands the affinity constants (KD ) of the sulfoconjugated CA under investigation were about 100- to 1000-fold higher
when compared with the respective free amines. Moreover, these sulfoconjugated CA
per se induced no intracellular production of cyclic adenosine monophosphate (cAMP)
in MNL. In comparison with the free amines, metanephrine (MN) and normeta-nephrine
(NMN) showed a highly reduced competitive potency on the MNL β-adrenoceptors labelled
with 3 H-CGP or ICYP. The Kd values for MN and NMN in competition studies with ICYP were
10- and 5-fold higher than in those with 3 H-CGP respectively, indicating a restricted access of MN and NMN to intracellular
receptors. The adenylate cyclase system was not stimulated at all by MN or by NMN.
In human platelets EPI-3-O-S and NE-3-O-S neither competed with the specific α2 -adrenoceptor antagonist 3 H-yohimbine nor elicited any aggregation response at all. MN and NMN exhibited an
about 40-fold reduced affinity for α2 -adrenoceptors in platelets when compared with the respective free amines and elicited
no aggregation response at all. However, in the presence of MN and NMN the EPI- and
NE-induced platelet aggregation was dose-dependently attenuated. These findings reveal
an β-adrenoceptor antagonistic potency of MN and NMN.
In human adipocytes EPI-3-O-S and NE-3-O-S were 100- to 1000-fold less potent to inhibit
lipid mobilization via α2 -adrenoceptors as well as to stimulate the β-adrenoceptor mediated lipolysis when
compared with free CA.
Key words
sulfoconjugated catecholamines - methylated catecholamines - human mononuclear leukocytes
- platelet - fatcell